Clinical Effects of Whole-body Hyperthermia in Advanced Malignancy
- 21 December 1974
- Vol. 4 (5946), 679-682
- https://doi.org/10.1136/bmj.4.5946.679
Abstract
Fifty-one patients in the terminal stages of cancer have been treated with whole-body hyperthermia either alone (38 cases) or in combination with chemotherapy (13 cases). Altogether 227 treatment sessions were held averaging four hours each. The most sensitive tumours were those of the gastrointestinal tract and sarcomas. Breast and genitourinary tumours did not respond, and lung tumours and melanomas were only partially responsive. Major complications were remarkably few.This publication has 14 references indexed in Scilit:
- Stimulation of tumour cell dissemination by raised temperature (42°C) in rats with transplanted Yoshida tumoursNature, 1974
- Disseminated intravascular coagulation in cancer patients: Supportive evidenceCancer, 1973
- Influence of drugs and synchrony on the hyperthermic killing of HeLa cells.1973
- Studies on the quantitative biology of hyperthermic killing of HeLa cells.1973
- INDUCTION OF CONTROLLED HYPERTHERMIA IN TREATMENT OF CANCERThe Lancet, 1971
- Disseminated intravascular coagulation—a complication of chemotherapy in acute myelomonocytic leukemiaCancer, 1970
- Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells.1970
- The in vitro oxygen uptake of tissues after hyperthermia.1970
- [Hyperthermia in the treatment of malignant diseases].1970
- Hyperthermic perfusion with chemotherapy for cancers of the extremities.1969